| Product NDC: | 0173-0602 |
| Proprietary Name: | FLOVENT |
| Non Proprietary Name: | fluticasone propionate |
| Active Ingredient(s): | 100 ug/1 & nbsp; fluticasone propionate |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | POWDER, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0602 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020833 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081013 |
| Package NDC: | 0173-0602-02 |
| Package Description: | 60 POWDER, METERED in 1 INHALER (0173-0602-02) |
| NDC Code | 0173-0602-02 |
| Proprietary Name | FLOVENT |
| Package Description | 60 POWDER, METERED in 1 INHALER (0173-0602-02) |
| Product NDC | 0173-0602 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluticasone propionate |
| Dosage Form Name | POWDER, METERED |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20081013 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | FLUTICASONE PROPIONATE |
| Strength Number | 100 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |